FinBERT, a financial-language model, scores this headline as positive (85% confidence). That is the news tone only — not the full stock rating.
Stocks › BNTX
Biontech Se (BNTX) stock analysis
SKIP 6% confidence · analysed Nov 3, 2026
On Nov 3, 2026, our model rated Biontech Se (BNTX) SKIP with 6% confidence at a price of $87.53. That means the signals cancel out; the model sees no clear edge either way.
Analysed price$87.53
Technical picture
The 14-day RSI is 45, close to the neutral 50 line, so momentum is balanced.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is only 0.6x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: bullish structure intact, no fresh break.
The most recent swing high is $120.33 and the swing low is $84.96; traders often treat these as resistance and support.
Fundamentals
The PEG ratio is 0.05, which looks cheap relative to its expected growth.
The company reports a profit margin of -63.6% and revenue growth of -59.5%.
In its latest quarter it earned $-2.22 per share, which missed the $-2.08 analysts expected, with revenue -59.5% year over year.
Wall Street's average rating is 1.7 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $116.77.
The next earnings report is expected around Nov 3, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.06 (SKIP). Technicals: RSI 45.45, MACD bullish, price below SMA50. Fundamentals: PEG 0.05, margin -63.6%, revenue growth -59.5%. Financial results: YoY revenue -59.5%, last EPS surprise -6.7%, next earnings 2026-11-03. Smart Money Concepts: bullish structure intact, no fresh break, sitting inside an unfilled bullish fair value gap. FinGPT news read: positive. Reference price $87.53; no trade levels (SKIP).
Past ratings for BNTX
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 3, 2026 | SKIP | 6% | $87.53 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on BNTX
Nov 3, 2026 · Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates
- Nov 3, 2026: Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates (Barrons.com)
- Nov 3, 2026: BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
Frequently asked questions
Is BNTX a buy right now?
As of Nov 3, 2026, our automated model rates Biontech Se (BNTX) SKIP with 6% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Biontech Se report earnings next?
The next earnings report is expected around Nov 3, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.